Inovio Pharmaceuticals Inc (INO)
4.06
+0.09
(+2.27%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2001 | 54.52% |
| June 30, 2001 | 56.18% |
| March 31, 2001 | |
| December 31, 2000 | 73.35% |
| September 30, 2000 | 62.72% |
| June 30, 2000 | 65.32% |
| Date | Value |
|---|---|
| March 31, 2000 | 62.26% |
| December 31, 1999 | 66.67% |
| September 30, 1999 | 80.00% |
| June 30, 1999 | 77.78% |
| March 31, 1999 | 94.57% |
| December 31, 1998 | 77.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Novavax Inc | 28.27% |
| Baxter International Inc | 38.27% |
| AIM ImmunoTech Inc | 77.14% |
| Protalix BioTherapeutics Inc | 53.37% |
| Armata Pharmaceuticals Inc | -- |